10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||
| ||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ABBVIE INC. | |||
Ticker: ABBV Fiscal Year: 2014 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2014 10-K (Filed: Feb 20, 2015) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | |
| Cash flows from operating activities | |||
| Net earnings | $ 1,774 | 4,128 | 5,275 |
| Adjustments to reconcile net earnings to net cash from operating activities: | |||
| Depreciation | 383 | 388 | 525 |
| Amortization of intangible assets | 403 | 509 | 625 |
| Stock-based compensation | 241 | 212 | 187 |
| Upfront costs related to collaborations and acquired in-process research and development | 1,102 | 338 | 288 |
| Other, net | 434 | 34 | 66 |
| Changes in operating assets and liabilities, net of acquisitions: | |||
| Accounts and other receivables | (172) | 681 | 223 |
| Inventories | (203) | (56) | (203) |
| Prepaid expenses and other assets | (220) | 459 | 90 |
| Accounts payable and other liabilities | (193) | (426) | (731) |
| Cash flows from operating activities | 3,549 [1] | 6,267 | 6,345 |
| Cash flows from investing activities | |||
| Acquisitions and investments, net of cash acquired | (622) | (405) | (688) |
| Acquisitions of property and equipment | (612) | (491) | (333) |
| Purchases of investment securities | (1,169) | (930) | (2,550) |
| Sales and maturities of investment securities | 1,477 | 2,705 | 1,153 |
| Cash flows from investing activities | (926) | 879 | (2,418) |
| Cash flows from financing activities | |||
| Net change in short-term borrowings | 12 | (601) | 1,000 |
| Dividends paid | (2,661) | (2,555) | |
| Purchases of treasury stock | (652) | (320) | |
| Proceeds from the exercise of stock options | 225 | 347 | |
| Proceeds from issuance of long-term debt | 14,586 | ||
| Net transactions with Abbott Laboratories, excluding noncash items | (247) | (13,504) | |
| Other, net | (217) | (66) | (151) |
| Cash flows from financing activities | (3,293) | (3,442) | 1,931 |
| Effect of exchange rate changes on cash and equivalents | (577) | (10) | 16 |
| Net (decrease) increase in cash and equivalents | (1,247) | 3,694 | 5,874 |
| Cash and equivalents, beginning of period | 9,595 | 5,901 | |
| Cash and equivalents, end of period | 8,348 | 9,595 | 5,901 |
| Other supplemental information | |||
| Interest paid, net of portion capitalized | 419 | 283 | 61 |
| Income taxes paid | 498 | 1,305 | |
| [1] Cash flows from operating activities included the impact of transaction and financing-related and other costs incurred in connection with the terminated proposed combination with Shire. Refer to Note 4 for additional information. | |||
| External Links | |
| ABBVIE INC. (ABBV) Fiscal Year 2014 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |